Basic Information
| LncRNA/CircRNA Name | miR143HG |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | HCC tissues,cell lines (huh7, hep3B, hepG2,smmc-7721,BEL-7402,HL-7702 (L02),HEK 293 T) |
| Expression Pattern | down-regulated |
| Function Description | The expression of miR143HG was significantly downregulated in HCC tissues and cells. |
| Pubmed ID | 30945380 |
| Year | 2019 |
| Title | Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma. |
External Links
| Links for miR143HG | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |